Peptilogics: Clinical Trials

2 trials sponsored by Peptilogics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Peptilogics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
PLG0206, Placebo - Prosthetic-joint Infection
Phase 2 / Phase 3RecruitingPeptilogics2402026-02-032026-11-20
Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)
PLG0206 - Joint Infection
Phase 1CompletedPeptilogics142022-03-312025-05-21

Interventions

Sodium Chloride (1)

Countries

United States (2)  ·  United Kingdom (1)